Myelodysplastic syndromes are a group of cancers that affect immature blood cells in the bone marrow. Two oncology navigators explain the risk factors and current treatment options available for patients diagnosed with this type of malignancy.
Last modified: February 19, 2020
Subscribe to CONQUER™: the patient voice™ magazine
Receive timely cancer news & updates, patient stories, and more.